Literature DB >> 6993474

Evidence that insulin activates an intrinsic plasma membrane protease in generating a secondary chemical mediator.

J R Seals, M P Czech.   

Abstract

Three lines of evidence are presented which support the hypothesis that the binding of insulin to rat adipocyte plasma membranes activates a membrane protease which results in the production of a soluble factor that stimulates pyruvate dehydrogenase activity when added to mitochondria. First, low concentrations of trypsin (0.01 to 0.1 microgram/ml) mimic the action of insulin on plasma membranes in this system. Second, inhibitors of trypsin-like proteases (soy trypsin inhibitor, ovomucoid) block insulin action on the plasma membrane, as do exogenous protease substrates which are esters of arginine, presumably by preventing the normal interaction of the protease and its endogenous membrane substrate. Third, digestion by proteases (0.1 mg/ml of trypsin, chymotrypsin, or papain) of the soluble material released from plasma membranes after insulin treatment blocks the stimulation of pyruvate dehydrogenase, suggesting that the mediator may be a peptide released by a proteolytic reaction.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6993474

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  Mechanisms of receptor-mediated transmembrane signalling.

Authors:  M D Hollenberg
Journal:  Experientia       Date:  1986-07-15

2.  Differential sensitivity of two functions of the insulin receptor to the associated proteolysis: kinase action and hormone binding.

Authors:  S Kathuria; S Hartman; C Grunfeld; J Ramachandran; Y Fujita-Yamaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  Biosynthesis of the endogenous cyclic adenosine monophosphate (AMP) antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), from prostaglandin E and activated inositol polyphosphate in rat liver plasma membranes.

Authors:  H K Wasner; M Lessmann; M Conrad; H Amini; E Psarakis; A Mir-Mohammad-Sadegh
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

4.  Involvement of hormone processing in insulin-activated glucose transport by isolated cardiac myocytes.

Authors:  J Eckel; H Reinauer
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

5.  Identification and characterization of a tissue kallikrein in rat skeletal muscles.

Authors:  N Shimojo; J Chao; L Chao; H S Margolius; R K Mayfield
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

Review 6.  D-chiro-inositol glycans in insulin signaling and insulin resistance.

Authors:  Joseph Larner; David L Brautigan; Michael O Thorner
Journal:  Mol Med       Date:  2010-08-27       Impact factor: 6.354

7.  Influence of a small molecular weight proteinase inhibitor, gabexate mesilate (FOY), on insulin receptor function in vitro.

Authors:  R Göke; B Göke; H J Steinfelder; R Arnold
Journal:  Int J Pancreatol       Date:  1988-03

8.  Possible involvement of normal p21 H-ras in the insulin/insulinlike growth factor 1 signal transduction pathway.

Authors:  B M Burgering; A J Snijders; J A Maassen; A J van der Eb; J L Bos
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

9.  Receptor-mediated insulin degradation and insulin-stimulated glycogenesis in cultured foetal hepatocytes.

Authors:  C Plas; B Desbuquois
Journal:  Biochem J       Date:  1982-02-15       Impact factor: 3.857

10.  Persistence of the effect of insulin on pyruvate dehydrogenase activity in rat white and brown adipose tissue during the preparation and subsequent incubation of mitochondria.

Authors:  R M Denton; J G McCormack; S E Marshall
Journal:  Biochem J       Date:  1984-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.